Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Return on Equity (2023 - 2025)

Immunocore Holdings' Return on Equity history spans 3 years, with the latest figure at 0.09% for Q4 2025.

  • For Q4 2025, Return on Equity rose 5.0% year-over-year to 0.09%; the TTM value through Dec 2025 reached 0.09%, up 5.0%, while the annual FY2025 figure was 0.1%, 4.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.09% at Immunocore Holdings, down from 0.07% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.05% in Q2 2025 and bottomed at 0.17% in Q1 2024.
  • The 3-year median for Return on Equity is 0.11% (2023), against an average of 0.11%.
  • The largest annual shift saw Return on Equity dropped -3bps in 2024 before it grew 11bps in 2025.
  • A 3-year view of Return on Equity shows it stood at 0.15% in 2023, then grew by 9bps to 0.14% in 2024, then soared by 34bps to 0.09% in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Return on Equity are 0.09% (Q4 2025), 0.07% (Q3 2025), and 0.05% (Q2 2025).